Shuangyan Ou

678 total citations
11 papers, 237 citations indexed

About

Shuangyan Ou is a scholar working on Molecular Biology, Hepatology and Cancer Research. According to data from OpenAlex, Shuangyan Ou has authored 11 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Hepatology and 4 papers in Cancer Research. Recurrent topics in Shuangyan Ou's work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Circular RNAs in diseases (3 papers) and MicroRNA in disease regulation (3 papers). Shuangyan Ou is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Circular RNAs in diseases (3 papers) and MicroRNA in disease regulation (3 papers). Shuangyan Ou collaborates with scholars based in China, United States and Japan. Shuangyan Ou's co-authors include Limin Chen, Yang Liu, Juan Tan, Jun Chen, Ruocai Xu, Hong Zheng, Wenli Zheng, Hong Zhou, Xin Fu and Dong Wei and has published in prestigious journals such as Scientific Reports, Medicine and Toxicology Letters.

In The Last Decade

Shuangyan Ou

10 papers receiving 235 citations

Peers

Shuangyan Ou
Mi Gao China
Adam De Jesus United States
Chenling Meng China
Carla Frau United States
Mingcui Ding China
Weiwei Dong China
Yalei Qi China
Meng‐Die Cheng China
Mi Gao China
Shuangyan Ou
Citations per year, relative to Shuangyan Ou Shuangyan Ou (= 1×) peers Mi Gao

Countries citing papers authored by Shuangyan Ou

Since Specialization
Citations

This map shows the geographic impact of Shuangyan Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuangyan Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuangyan Ou more than expected).

Fields of papers citing papers by Shuangyan Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuangyan Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuangyan Ou. The network helps show where Shuangyan Ou may publish in the future.

Co-authorship network of co-authors of Shuangyan Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Shuangyan Ou. A scholar is included among the top collaborators of Shuangyan Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuangyan Ou. Shuangyan Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Liang, Lin, et al.. (2025). The immune-related prognostic gene AIM2 promotes pancreatic cancer progression via inflammasome. Scientific Reports. 15(1). 29733–29733.
2.
3.
Yuan, Xia, Mao Ye, & Shuangyan Ou. (2023). Diagnostic accuracy of circulating exosomal circRNAs in malignances: A meta-analysis and systematic review. Medicine. 102(21). e33872–e33872. 5 indexed citations
4.
Zhang, Congjun, Shuangyan Ou, Yuan Zhou, et al.. (2021). m6A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer. Frontiers in Oncology. 11. 696371–696371. 31 indexed citations
5.
Liu, Yang, Juan Tan, Shuangyan Ou, Jun Chen, & Limin Chen. (2019). Adipose-derived exosomes deliver miR-23a/b to regulate tumor growth in hepatocellular cancer by targeting the VHL/HIF axis. Journal of Physiology and Biochemistry. 75(3). 391–401. 81 indexed citations
6.
Liu, Yang, Juan Tan, Shuangyan Ou, Jun Chen, & Limin Chen. (2019). MicroRNA-101-3p suppresses proliferation and migration in hepatocellular carcinoma by targeting the HGF/c-Met pathway. Investigational New Drugs. 38(1). 60–69. 21 indexed citations
7.
Li, Jian‐Liang, Xiaoping Yu, Qian Liu, et al.. (2019). Screening of important lncRNAs associated with the prognosis of lung adenocarcinoma, based on integrated bioinformatics analysis. Molecular Medicine Reports. 19(5). 4067–4080. 6 indexed citations
8.
Ou, Shuangyan, Ruocai Xu, Ke Li, et al.. (2018). Radiofrequency ablation with systemic chemotherapy in the treatment of colorectal cancer liver metastasis: a 10-year single-center study. Cancer Management and Research. Volume 10. 5227–5237. 16 indexed citations
9.
Xu, Ruocai, Jian‐Liang Li, Ke Li, et al.. (2015). Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma. Current Medical Research and Opinion. 31(8). 1553–1560. 7 indexed citations
10.
Jiang, Yue‐Ming, Liling Long, Hong Zheng, et al.. (2008). Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: A study by magnetic resonance imaging and 1H magnetic resonance spectroscopy. Toxicology Letters. 181(2). 118–125. 42 indexed citations
11.
Sakao, Yukinori, Hideaki Miyamoto, Shuangyan Ou, et al.. (2006). The spread of metastatic lymph nodes to the mediastinum from left upper lobe cancer: results of superior mediastinal nodal dissection through a median sternotomy. European Journal of Cardio-Thoracic Surgery. 30(3). 543–547. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mi Gao Breakdown of academic impact, for papers by Adam De Jesus Breakdown of academic impact, for papers by Chenling Meng Breakdown of academic impact, for papers by Carla Frau Breakdown of academic impact, for papers by Mingcui Ding Breakdown of academic impact, for papers by Weiwei Dong Breakdown of academic impact, for papers by Yalei Qi Breakdown of academic impact, for papers by Meng‐Die Cheng
Rankless by CCL
2026